2026 EPS guidance raised, expecting 5% growth at midpoint
Globe Life reported strong FY2025 earnings and raised 2026 guidance, driven by robust growth in health (particularly Medicare supplement) and improving life margins. Management highlighted a structural shift from Medicare Advantage to Med Supp, the launch of a Bermuda reinsurer for capital efficiency, and continued agent productivity gains. FY2025 net operating income per share $14.52, slightly above prior guidance midpoint; Q4 EPS $3.39 (+8% YoY).
Buzzberg read2026 EPS guidance raised, expecting 5% growth at midpointGlobe Life reported strong FY2025 earnings and raised 2026 guidance, driven by robust growth in health (particularly Medicare supplement) and improving life margins. Management highlighted a structural shift from Medicare Advantage to Med Supp, the launch of a Bermuda reinsurer for capital efficiency, and continued agent productivity gains. FY2025 net operating income per share $14.52, slightly above prior guidance midpoint; Q4 EPS $3.39 (+8% YoY).Read full analysisCollapse analysis
Globe Life reported strong FY2025 earnings and raised 2026 guidance, driven by robust growth in health (particularly Medicare supplement) and improving life margins. Management highlighted a structural shift from Medicare Advantage to Med Supp, the launch of a Bermuda reinsurer for capital efficiency, and continued agent productivity gains. FY2025 net operating income per share $14.52, slightly above prior guidance midpoint; Q4 EPS $3.39 (+8% YoY).
Health premium growth guided to 14–16% in 2026, driven by strong Med Supp sales and rate increases; United American sales doubled in 2025.
Demand & capex
Demand
Bookings & conversion
Management raised 2026 EPS guidance citing continued favorable mortality trends, strong sales momentum across multiple distribution channels, and a constructive outlook for Medicare supplement. Normalized EPS growth of ~10% underpins a confident tone.
Capex
Investment and capacity
Management discussed continued technology investments aimed at improving agent productivity and direct-to-consumer lead conversion, with more enhancements expected in 2026 and 2027, but provided no specific capital expenditure figures.
Tone · Confident
Management expressed confidence in growth opportunities across divisions, citing strong sales momentum, favorable mortality trends, and strategic initiatives like the Bermuda reinsurance entity, while acknowledging manageable headwinds such as agent turnover and health margin mix.
Supply-chain alpha
A1
A major shift in the Medicare market is underway: beneficiaries are moving from Medicare Advantage plans to Medicare Supplement plans due to MA reimbursement cuts and provider network constraints, fueling Globe Life's 50% sales surge at United American in 2025.
“We attribute this tremendous growth primarily to the significant movement of Medicare beneficiaries from Medicare Advantage plans to Medicare Supplement plans.”
Globe Life launched a Bermuda reinsurance subsidiary, transferring $1.2B of statutory reserves in 2025, and expects to grow annual parent cash flow toward $200M as the block builds, enhancing capital flexibility without relying on US subsidiary dividends.
“We anticipate parents' annual excess cash flow will increase over time toward $200 million as earnings emerge from reinsurance additional, in-force, and new business.”
A major shift in the Medicare market is underway: beneficiaries are moving from Medicare Advantage plans to Medicare Supplement plans due to MA reimbursement cuts and provider network constraints, fueling Globe Life's 50% sales surge at United American in 2025. — This structural shift pressures MA carriers (UNH, HUM, CVS) on enrollment and margins, while benefiting Med Supp writers like Globe Life.
… and here the health premiums increased 14% over the year-ago quarter, to $173 million, and this is driven by sales growth and Medicare supplement rate increases that we have discussed previously. Health underwriting margin was $8 million, up $2 million from the year-ago quarter. Strong activity across the entire agency resulted in net health sales of $77 million, an increase of approximately $47 million over the year-ago quarter. We attribute this tremendous growth primarily to the significant movement of Medicare beneficiaries from Medicare Advantage plans to Medicare Supplement plans. As a reminder, we do not market Medicare Advantage plans. Now I'd like to discuss our projections, and based on recent trends in our experience with our business, we expect the average producing agent count trends for the full year 2026 to be as follows. At American income, mid-single-digit growth, Liberty National, high single-digit growth, and at Family Heritage, low double-digit growth. Net life sales for 2026 are expected to be as follows. At American income, high single-digit growth, Liberty National, low double-digit growth, and direct-to-consumer, mid-single-digit growth. Net health sales …
🍪 Cookies
We use cookies to operate this site and for analytics. Declining won't affect your access to content.